Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL503P is a pseudogene derived from the 7SL RNA family, which encodes a non-coding RNA involved in the formation of the signal recognition particle (SRP). The SRP is essential for protein targeting to the endoplasmic reticulum in eukaryotic cells[3]. However, as a pseudogene, RN7SL503P lacks the functional elements necessary for transcription or translation into an active product, and there is no evidence it plays a biological role[4][5][6]. Pseudogenes can occasionally be transcribed at low levels, but most are nonfunctional remnants of gene duplication or retrotransposition events[6]. There is no indication that RN7SL503P is involved in disease, interacts with drugs, serves as a biomarker, or is associated with safety issues. Supporting Details: - The parental gene, 7SL RNA, is a critical RNA component of the signal recognition particle (SRP), but RN7SL pseudogenes such as RN7SL503P are truncated, mutated, and lack promoters, rendering them nonfunctional[5][6][4]. - Pseudogenes may be mistakenly amplified in molecular assays but generally do not have biological activity or therapeutic relevance[6]. - No drugs, disease processes, or therapeutic mechanisms are described for this pseudogene. In summary, RN7SL503P is a nonfunctional pseudogene unrelated to any known therapeutic or diagnostic use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 503, pseudogene (RN7SL503P).